By my reckoning, IF the CD19/CF33 CAR-T trial should succeed and cure solid tumour, IMU will way surpass CSL. I have posted before the market size of solid tumour can reach up to US$474bn by 2027. If my maths is correct, even just taking 10% of that is about US$50bn/ year. At a PE of just 20 will give IMU a market cap of US$1 trillion dollar.
I know it is mind blowing, but that is the real potential here. But of course, there is a big IF the trial works.
Media Thread, page-1350
-
- There are more pages in this discussion • 12,918 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
